Related Experiment Videos
C-peptide, Na+,K(+)-ATPase, and diabetes
P Vague1, T C Coste, M F Jannot
1Departement de Nutrition-Endocrinologie-Maladies Métaboliques, CHU Timone, Marseille, France. philippe.vague@ap-hm.fr
Experimental Diabesity Research
|June 17, 2004
Summary
Reduced Na+,K(+)-ATPase activity in diabetes is linked to low C-peptide levels. Restoring C-peptide levels can improve enzyme function and potentially prevent diabetic complications.
Area of Science:
- Biochemistry
- Endocrinology
- Cell Biology
Background:
- Na+,K(+)-ATPase is a crucial membrane enzyme regulating ion transport, with decreased activity observed in diabetic conditions.
- Impaired Na+,K(+)-ATPase function is implicated in the development of diabetic complications, affecting tissues like red blood cells and nerves.
- Type 1 diabetic individuals show reduced Na+,K(+)-ATPase activity, while type 2 diabetic patients exhibit less impairment, suggesting varying underlying mechanisms.
Purpose of the Study:
- To investigate the relationship between Na+,K(+)-ATPase activity and C-peptide levels in diabetic patients.
- To explore the role of C-peptide in regulating Na+,K(+)-ATPase activity and its potential therapeutic implications for diabetic complications.
- To examine the gene-environment interactions, specifically the ATP1A1 gene polymorphism, associated with Na+,K(+)-ATPase activity in diabetes.
Main Methods:
- Assessed Na+,K(+)-ATPase activity in red blood cells of type 1 and type 2 diabetic patients.
- Correlated enzyme activity with blood C-peptide levels in different diabetic patient groups.
- Investigated the effects of C-peptide infusion and islet transplantation on Na+,K(+)-ATPase activity in animal models and human patients.
Main Results:
- Na+,K(+)-ATPase activity in type 2 diabetic patients strongly correlated with C-peptide levels.
- A polymorphism in the ATP1A1 gene (intron 1) was associated with lower enzyme activity in C-peptide deficient diabetic individuals.
- C-peptide infusion and islet transplantation effectively restored Na+,K(+)-ATPase activity in diabetic models and patients.
Conclusions:
- Low C-peptide levels are a primary cause of reduced Na+,K(+)-ATPase activity in diabetes.
- The impairment in Na+,K(+)-ATPase activity contributes to microvascular dysfunction, reduced red blood cell deformability, and diabetic neuropathy.
- Physiological C-peptide infusion shows promise for preventing or treating diabetic complications by restoring Na+,K(+)-ATPase function.